Form4insider filings, from the source

SEC Form 4 · accession 0001140361-17-021428

OncoMed Pharmaceuticals Inc · OMED

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
May 16, 2017
Accepted (ET)
May 18, 2017 · 6:43 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001302573

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1May 16, 2017P23,507$3.4909A131,095D
Common StockF2holding———1,119,905ISee Footnote
Common StockF3holding———380,299ISee Footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses